The newly added employer is a nationally strategic institution with a central role in U.S. healthcare and technology ...

PhaseV, a leader in AI/ML-driven clinical development, today announced its participation in several upcoming biotech and data science conferences. The company will showcase its advancements in ...

For the full year 2024, YXT reported its net loss narrowed 59.9% to RMB92.1 million ($12.6 million), from RMB229.8 million ...

QKS Group, a premier market intelligence and advisory firm, has unveiled its latest comprehensive analysis of the global Bot ...

Caristo Diagnostics, on a mission to transform the diagnosis and treatment of cardiovascular disease, today announced that ...

Squirro, a leading enterprise GenAI platform provider, today announced that it has promoted its dynamic Chief Marketing Officer, Lauren Hawker Zafer, to the role of Chief Operating Officer. As the ...

Enterprises can now confidently test AI accuracy, streamline workflows, and validate performance beforedeployment. SANDNES, Norway, April 8, 2025 /PRNewswire/ -- boost.ai today announced ...

Three years ago. Five missed calls. Ada, my colleague. My chest tightened. I didn’t need to check to know what this was about ...

CAS, a division of the American Chemical Society specializing in scientific content and knowledge management, and Cleveland Clinic, an academic ...

A new artificial intelligence (AI) tool that can help interpret and assess how well treatments are working for patients with multiple sclerosis (MS) has been developed by UCL researchers.

ChatGPT's viral AI image generator is now free in the UK - how to use - How to use the new AI tool and the best prompts for ...

Biosensors are changing how we monitor health, but rapid innovation raises tough questions around privacy, regulation, and ...